methamphetamine has been researched along with eticlopride in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGinty, JF; Wang, JQ | 1 |
| Marshall, JF; O'Dell, SJ; Weihmuller, FB | 2 |
| Akiyama, K; Hamamura, T; Ishihara, T; Kashihara, K; Kuroda, S; Okada, S; Ujike, H | 1 |
| Baucum, AJ; Cook, GA; Fleckenstein, AE; Gibb, JW; Hadlock, GC; Hanson, GR; Horner, KA; King, JL; Wilkins, DG | 1 |
| Brennan, KA; Carati, C; Fitzmaurice, PS; Lea, RA; Schenk, S | 1 |
| Chu, PW; Fleckenstein, AE; Hadlock, GC; Hanson, GR; Walters, ET | 1 |
| Chu, PW; Fleckenstein, AE; Hadlock, GC; Hanson, GR; Stout, K; Vieira-Brock, P | 1 |
| Alburges, ME; Cordova, NM; Hanson, GR; Hoonakker, AJ; Martin, AL; McFadden, LM; Robson, CM | 1 |
| Cai, WT; Kim, JH; Lee, YH; Lee, YS; Park, KT; Yoon, HS | 1 |
10 other study(ies) available for methamphetamine and eticlopride
| Article | Year |
|---|---|
Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.
Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; DNA-Binding Proteins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Early Growth Response Protein 1; Immediate-Early Proteins; Male; Methamphetamine; Prosencephalon; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Salicylamides; Time Factors; Transcription Factors | 1995 |
Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.
Topics: Animals; Benzazepines; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Glutamates; Glutamic Acid; Male; Methamphetamine; Microchemistry; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Salicylamides | 1993 |
Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Corpus Striatum; Dialysis; Dopamine; Dopamine D2 Receptor Antagonists; Male; Methamphetamine; Nerve Endings; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides | 1993 |
Activator protein-1 binding activities in discrete regions of rat brain after acute and chronic administration of methamphetamine.
Topics: Animals; Base Sequence; Benzazepines; Corpus Striatum; DNA-Binding Proteins; Drug Administration Schedule; Fos-Related Antigen-2; Male; Methamphetamine; Molecular Sequence Data; Nucleus Accumbens; Oligodeoxyribonucleotides; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Salicylamides; Stereotyped Behavior; Transcription Factor AP-1; Transcription Factors | 1996 |
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Topics: Animals; Benzazepines; Blotting, Western; Data Interpretation, Statistical; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Methamphetamine; Neostriatum; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Sympathectomy, Chemical; Synaptosomes | 2009 |
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
Topics: Animals; Antipsychotic Agents; Benzazepines; Central Nervous System; Cocaine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Self Administration | 2009 |
Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
Topics: Animals; Astrocytes; Blotting, Western; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glial Fibrillary Acidic Protein; Male; Methamphetamine; Molecular Weight; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Vesicular Monoamine Transport Proteins | 2010 |
Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Male; Methamphetamine; Potassium; Rats; Rats, Sprague-Dawley; Salicylamides; Subcellular Fractions; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Topics: Animals; Basal Ganglia; Benzazepines; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methamphetamine; Neurotensin; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Self Administration | 2014 |
The expression of methiopropamine-induced locomotor sensitization requires dopamine D2, but not D1, receptor activation in the rat.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Thiophenes | 2016 |